S&W Seed CO 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
S&W Seed Company has entered into an agreement to sell its sorghum business collateral for approximately $7.0 million cash plus deferred payments to satisfy debt obligations with Mountain Ridge.
OTC.Pink
S&W Seed Company is facing the private disposition of substantially all its assets by its lender, ABL OPCO LLC, to satisfy an approximately $19.0 million debt obligation after defaulting on its credit agreement.
OTC.Pink
S&W Seed Company announced its voluntary delisting from Nasdaq and deregistration with the SEC, citing non-compliance with listing requirements, high costs, and financial defaults, while securing additional high-interest revolving loans.
OTC.Pink
S&W Seed Company obtained an additional $150,000 in high-interest revolving loans from Mountain Ridge, incurring an $85,000 funding fee, primarily to cover payroll and professional services.
OTC.Pink
S&W Seed Company announced a default on its primary credit facility, triggering cross-defaults, leading to the termination of its CEO, significant layoffs, and the exploration of strategic alternatives including potential bankruptcy or liquidation.
OTC.Pink
S&W Seed Company reported a 2.0% increase in revenue and a positive Adjusted EBITDA for the third quarter of fiscal 2025, but revised its full-year guidance due to tariff impacts and market uncertainty.
OTC.Pink
S&W Seed Company reports a decrease in revenue and an increased net loss for the second quarter of fiscal year 2025, while focusing on core Americas-based operations and exploring strategic alternatives.
OTC.Pink
S&W Seed Company projects significant growth in sorghum sales and improved gross margins over the next decade, driven by new product launches and market share gains.
OTC.Pink
S&W Seed Company has entered into a new $25 million credit agreement with Mountain Ridge, using initial funds to repay its debt with CIBC Bank, and repurchased 200,000 shares from MFP Partners.
OTC.Pink
S&W Seed Company held its annual meeting on December 17, 2024, where stockholders elected directors, ratified the accounting firm, approved executive compensation, and amended the equity incentive plan.
OTC.Pink
S&W Seed Company has extended its loan maturity date with CIBC Bank USA and regained compliance with Nasdaq listing rules.
OTC.Pink
S&W Seed Company completed the transfer of its Australian subsidiary, S&W Australia, to Avior Asset Management, releasing itself from significant debt guarantees and intercompany liabilities.
OTC.Pink
S&W Seed Company announced its first quarter fiscal year 2025 results, reporting a revenue decrease and a net loss, while also finalizing the restructuring of its Australian subsidiary.
OTC.Pink
S&W Seed Company reported a decrease in revenue and gross profit margin for the first quarter of fiscal year 2025, while also announcing new guidance and a focus on its core Americas operations following the conclusion of the Voluntary Administration process for its Australian business.
OTC.Pink
S&W Seed Company has received notification from Nasdaq confirming they have regained compliance with minimum bid price and timely financial reporting rules.
OTC.Pink
S&W Seed Company announced its fiscal year 2024 financial results, highlighting a revenue decrease but improved gross profit margins, while also addressing challenges in its international operations.
OTC.Pink
S&W Seed Company received a delisting notice from Nasdaq for failing to file its annual report and has restated previous quarterly financials due to segment reporting errors.
OTC.Pink
S&W Seed Company will implement a 1-for-19 reverse stock split effective October 17, 2024, to increase the per-share price of its common stock.
OTC.Pink
S&W Seed Company's stockholders have approved a reverse stock split at a ratio between 1-for-5 and 1-for-20, to be determined by the Board of Directors.
OTC.Pink
S&W Seed Company's Australian subsidiary entered voluntary administration, leading to a loan default, which was subsequently waived by CIBC Bank USA with specific conditions.
OTC.Pink
S&W Seed Company's Australian subsidiary, S&W Australia, has entered voluntary administration due to insolvency concerns, triggering defaults on key loan agreements.
OTC.Pink
S&W Seed Company has amended its loan agreement with MFP Partners, extending the maturity dates for both a letter of credit and the overall loan.
OTC.Pink
S&W Seed Company has amended its loan agreement with CIBC Bank USA, extending the maturity date to October 31, 2024, and adjusting loan commitment amounts and inventory sublimits.
OTC.Pink
S&W Seed Co. has amended its employment agreement with CEO Mark Herrmann, detailing his compensation structure for fiscal year 2025 and beyond.
OTC.Pink
S&W Seed Company has been granted an extension until November 11, 2024, by Nasdaq to regain compliance with the minimum bid price requirement for continued listing.
OTC.Pink
S&W Seed Company's Q3 fiscal 2024 results show revenue growth but are impacted by international disruptions and reduced guidance.
OTC.Pink
S&W Seed Company has made an updated corporate presentation available on its website, intended for use in discussions with investors and analysts.
OTC.Pink
S&W Seed Company has dismissed Crowe LLP as its independent auditor and engaged Grant Thornton LLP, effective for the fiscal year ending June 30, 2024.
OTC.Pink
S&W Seed Company's second quarter fiscal 2024 results show a revenue decrease, but improved gross margins driven by strong Double Team sorghum sales, alongside the appointment of a new CFO.